4//SEC Filing
HENRY CHRISTIAN O 4
Accession 0000950170-25-108287
CIK 0001631574other
Filed
Aug 12, 8:00 PM ET
Accepted
Aug 13, 8:00 PM ET
Size
9.4 KB
Accession
0000950170-25-108287
Insider Transaction Report
Form 4
HENRY CHRISTIAN O
Director
Transactions
- Sale
Ordinary Shares
2025-08-13$8.81/sh−9,670$85,193→ 29,645 total - Award
Ordinary Shares
2025-08-11+12,700→ 39,315 total - Award
Share Option (right to buy)
2025-08-11+76,200→ 76,200 totalExercise: $8.11Exp: 2030-08-11→ Ordinary Shares (76,200 underlying)
Footnotes (4)
- [F1]The reporting person was granted this restricted share unit award (RSU) pursuant to the 2025 Non-Employee Director Compensation Policy. The RSU vests as to 100% of the shares on the earlier of the Company's 2026 annual general meeting or August 11, 2026.
- [F2]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 24, 2024.
- [F3]The price reflected is the weighted-average sale price for shares sold. The shares were sold in multiple transactions and the range of sale prices for the transactions reported was $8.45 to $9.03 per share. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
- [F4]The reporting person was granted this option pursuant to the 2025 Non-Employee Director Compensation Policy. The option vests as to 100% of the shares on the earlier of the Company's 2026 annual general meeting or August 11, 2026
Documents
Issuer
Wave Life Sciences Ltd.
CIK 0001631574
Entity typeother
Related Parties
1- filerCIK 0001263805
Filing Metadata
- Form type
- 4
- Filed
- Aug 12, 8:00 PM ET
- Accepted
- Aug 13, 8:00 PM ET
- Size
- 9.4 KB